. 2020 Nov 28;100(2):592–602. doi: 10.1016/j.psj.2020.11.039

Table 2.

Flow cytometric analysis of CD4⁺ and CD8⁺ T cells (%).

T lymphocyte	Groups	D11	D18	D25	D32
CD4
	BC	68.53 ± 0.50^b	64.83 ± 0.58^d	66.00 ± 0.70^b	64.80 ± 0.61^b
	VC	72.67 ± 1.16^a	68.70 ± 0.78^c	69.93 ± 0.78^b	67.03 ± 2.11^b
	MLP-L	75.37 ± 0.79^a	72.70 ± 1.08^b	69.30 ± 1.48^b	66.43 ± 2.84^b
	MLP-M	75.67 ± 0.52^a	74.33 ± 1.05^a,b	74.50 ± 1.31^a	72.87 ± 1.24^a
	MLP-H	74.40 ± 1.43^a	75.83 ± 0.26^a	73.90 ± 0.67^a	70.63 ± 0.74^a,b
CD8
	BC	65.33 ± 0.88^c	64.50 ± 1.18^b	71.60 ± 1.49^b,c	63.40 ± 1.49^c
	VC	68.60 ± 1.35^b,c	66.23 ± 1.10^b	70.20 ± 1.00^c	66.03 ± 2.26^b,c
	MLP-L	71.47 ± 0.71^b	72.13 ± 0.27^a	75.40 ± 1.86^b	68.43 ± 2.60^b
	MLP-M	79.93 ± 1.59^a	72.50 ± 0.35^a	77.80 ± 1.17^b	80.40 ± 2.83^a
	MLP-H	77.97 ± 1.07^a	71.17 ± 0.50^a	83.53 ± 0.87^a	73.90 ± 1.65^a,b

^a–dData in the same column without the same superscript differ significantly (P < 0.05).

Abbreviations: BC, blank control; D11, day 7; D18, day 14; D25, day 21; D32, day 28; MLP, mulberry leaf polysaccharide; MLP-L, MLP at a dose of 2 mg; MLP-M, MLP at a dose of 4 mg; MLP-H, MLP at a dose of 8 mg; VC, vaccine control.